Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
Baulac M, Rosenow F, Toledo M, Terada K, Li T, De Backer M, Werhahn KJ, Brock M. Baulac M, et al. Among authors: werhahn kj. Lancet Neurol. 2017 Jan;16(1):43-54. doi: 10.1016/S1474-4422(16)30292-7. Epub 2016 Nov 24. Lancet Neurol. 2017. PMID: 27889312 Clinical Trial.
Efficacy and safety of adjunctive padsevonil in adults with drug-resistant focal epilepsy: Results from two double-blind, randomized, placebo-controlled trials.
Rademacher M, Toledo M, Van Paesschen W, Liow KK, Milanov IG, Esch ML, Wang N, MacPherson M, Byrnes WJ, Minh TDC, Webster E, Werhahn KJ. Rademacher M, et al. Among authors: werhahn kj. Epilepsia Open. 2022 Dec;7(4):758-770. doi: 10.1002/epi4.12656. Epub 2022 Oct 22. Epilepsia Open. 2022. PMID: 36176044 Free PMC article. Clinical Trial.
Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.
Pohlmann-Eden B, Marson AG, Noack-Rink M, Ramirez F, Tofighy A, Werhahn KJ, Wild I, Trinka E. Pohlmann-Eden B, et al. Among authors: werhahn kj. BMC Neurol. 2016 Aug 23;16(1):149. doi: 10.1186/s12883-016-0663-7. BMC Neurol. 2016. PMID: 27552848 Free PMC article. Clinical Trial.
Padsevonil randomized Phase IIa trial in treatment-resistant focal epilepsy: a translational approach.
Muglia P, Hannestad J, Brandt C, DeBruyn S, Germani M, Lacroix B, Majoie M, Otoul C, Sciberras D, Steinhoff BJ, Van Laere K, Van Paesschen W, Webster E, Kaminski RM, Werhahn KJ, Toledo M. Muglia P, et al. Among authors: werhahn kj. Brain Commun. 2020 Nov 2;2(2):fcaa183. doi: 10.1093/braincomms/fcaa183. eCollection 2020. Brain Commun. 2020. PMID: 33241213 Free PMC article.
[Suggestion for a new, patient-oriented epilepsy classification].
Kellinghaus C, Loddenkemper T, Wyllie E, Najm I, Gupta A, Rosenow F, Baumgartner C, Boesebeck F, Diehl B, Drees C, Ebner A, Hamer H, Knake S, Meencke JH, Merschhemke M, Möddel G, Noachtar S, Rona S, Schuele SU, Steinhoff BJ, Tuxhorn I, Werhahn K, Lüders HO; ILAE Task Force for Epilepsy Classification. Kellinghaus C, et al. Nervenarzt. 2006 Aug;77(8):961-9. doi: 10.1007/s00115-006-2123-x. Nervenarzt. 2006. PMID: 16821062 German.
The Wada test in Austrian, Dutch, German, and Swiss epilepsy centers from 2000 to 2005: a review of 1421 procedures.
Haag A, Knake S, Hamer HM, Boesebeck F, Freitag H, Schulz R, Baum P, Helmstaedter C, Wellmer J, Urbach H, Hopp P, Mayer T, Hufnagel A, Jokeit H, Lerche H, Uttner I, Meencke HJ, Meierkord H, Pauli E, Runge U, Saar J, Trinka E, Benke T, Vulliemoz S, Wiegand G, Stephani U, Wieser HG, Rating D, Werhahn K, Noachtar S, Schulze-Bonhage A, Wagner K, Alpherts WC, Boas Wv, Rosenow F; Arbeitsgemeinschaft für Prächirurgische Epilepsiediagnostik und Operative Epilepsietherapie e.V. Haag A, et al. Epilepsy Behav. 2008 Jul;13(1):83-9. doi: 10.1016/j.yebeh.2008.02.012. Epub 2008 Mar 20. Epilepsy Behav. 2008. PMID: 18358786 Review.
69 results